Setazindol
Setazindol
Setazindol (pronunciation: se-ta-zin-dol) is a pharmaceutical drug that was developed in the late 20th century. It is classified as an anorectic, a type of drug that suppresses or reduces appetite.
Etymology
The term "Setazindol" is derived from the systematic IUPAC name of the drug, which is "2-(3,4-dichlorophenyl)-3-(1-piperazinyl)-2,3-dihydro-1H-isoindol-1-one". The name "Setazindol" is a simplification of this systematic name.
Usage
Setazindol is used in the treatment of obesity. It works by suppressing the appetite, thereby reducing the amount of food intake. This helps in weight loss and management. However, it is not a standalone treatment for obesity and should be used in conjunction with a healthy diet and regular exercise.
Side Effects
Like all drugs, Setazindol can have side effects. These can include dry mouth, constipation, insomnia, and increased heart rate. It is important to consult a healthcare professional before starting any new medication.
Related Terms
- Anorectic: A type of drug that suppresses or reduces appetite.
- Obesity: A medical condition in which excess body fat has accumulated to the extent that it may have a negative effect on health.
- IUPAC: The International Union of Pure and Applied Chemistry, an international federation of National Adhering Organizations that represents chemists in individual countries.
External links
- Medical encyclopedia article on Setazindol
- Wikipedia's article - Setazindol
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski